enVVeno Medical (NVNO) Preferred Stock Liabilities (2017)

enVVeno Medical's (NVNO) quarterly Preferred Stock Liabilities came in at $3.9 million in Q4 2017.

enVVeno Medical (NVNO) Preferred Stock Liabilities (2017) Analysis & Trends

enVVeno Medical's Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $3.9 million for Q4 2017.

On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $3.9 million in Q4 2017; TTM through Dec 2017 was $3.9 million, a N/A change from a year earlier, with the FY2017 full-year figure at $3.9 million, changed N/A from the prior year.
Preferred Stock Liabilities steadied at $3.9 million in Q4 2017 per NVNO's latest filing.
Across five years, Preferred Stock Liabilities topped out at $3.9 million in Q4 2017 and bottomed at $3.9 million in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Abbott Laboratories	184.16 Bn	176.87 Bn	6.27 Bn	-
2	Stryker	128.86 Bn	125.98 Bn	3.81 Bn	-
3	Medtronic	108.89 Bn	99.67 Bn	6.41 Bn	-
4	Boston Scientific	68.54 Bn	67.08 Bn	3.61 Bn	-
5	Edwards Lifesciences	47.44 Bn	43.76 Bn	1.29 Bn	-
6	GE HealthCare Technologies	28.45 Bn	26.16 Bn	1.98 Bn	-
7	Dexcom	28.36 Bn	27.24 Bn	750.30 Mn	-
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	25.54 Bn	22.42 Bn	2.07 Bn	-
10	enVVeno Medical	6.86 Mn	6.86 Mn	-	-

Download Data

Date	Value
Dec 31, 2017	3.94 Mn